Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Biogen Inc (NASDAQ:BIIB)

318.17
Delayed Data
As of Aug 23
 +1.36 / +0.43%
Today’s Change
223.02
Today|||52-Week Range
333.65
+3.86%
Year-to-Date
Biotechs Rally on Pfizer/Medivation Deal
Aug 22 / TheStreet.com - Paid Partner Content
Top 3 Research Reports for August 15, 2016
Aug 15 / Zacks.com - Paid Partner Content
Gilead May Be Better Off Splitting Itself in Two, Analysts Say
Aug 18 / TheStreet.com - Paid Partner Content
Allergan to Buy ForSight VISION5, Boost Glaucoma Pipeline
Aug 15 / Zacks.com - Paid Partner Content
Biotech Stock Roundup: Vertex Slips on Study Halt, Aurinia Plunges on Lupus Data
Aug 17 / Zacks.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Regeneron, BioMarin, AbbVie, Amgen and Biogen
Aug 12 / Zacks.com - Paid Partner Content
Better Buy: Amgen Inc. vs. Biogen
Aug 17 / MotleyFool.com - Paid Partner Content
Biotech Stock Roundup: Earnings in Focus, AbbVie Takes Steps to Block Humira Copycat
Aug 11 / Zacks.com - Paid Partner Content
Ionis Pharmaceuticals Inc Begins to Shift Focus
Aug 16 / MotleyFool.com - Paid Partner Content
Ionis (IONS) Q2 Loss Narrower than Expected, Issues Outlook
Aug 10 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close316.81
Today’s open316.81
Day’s range315.28 - 322.99
Volume1,429,298
Average volume (3 months)1,918,328
Market cap$69.4B
Dividend yield--
Data as of 08/23/2016

Growth & Valuation

Earnings growth (last year)+24.01%
Earnings growth (this year)+16.25%
Earnings growth (next 5 years)+9.00%
Revenue growth (last year)-3.87%
P/E ratio18.6
Price/Sales7.60
Price/Book7.39

Competitors

 Today’s
change
Today’s
% change
GILDGilead Sciences+0.55+0.68%
BAXBaxter International...0.000.00%
ILMNIllumina Inc-0.96-0.55%
AMGNAmgen+0.05+0.03%
Data as of 08/23/2016

Financials

Next reporting dateOctober 19, 2016
EPS forecast (this quarter)$5.00
Annual revenue (last year)$9.3B
Annual profit (last year)$3.5B
Net profit margin38.05%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
George A. Scangos
Chief Scientific Officer &
Executive VP
Spyridon Artavanis-Tsakonas
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Partner Offers

Search for Jobs